These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4024658)

  • 1. Oxidative metabolism of carbazeran in vitro by liver cytosol of baboon and man.
    Kaye B; Rance DJ; Waring L
    Xenobiotica; 1985 Mar; 15(3):237-42. PubMed ID: 4024658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A species difference in the presystemic metabolism of carbazeran in dog and man.
    Kaye B; Offerman JL; Reid JL; Elliott HL; Hillis WS
    Xenobiotica; 1984 Dec; 14(12):935-45. PubMed ID: 6531941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment.
    Critchley DJ; Rance DJ; Beedham C
    Xenobiotica; 1994 Jan; 24(1):37-47. PubMed ID: 8165820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
    Zientek M; Jiang Y; Youdim K; Obach RS
    Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species variation in hepatic aldehyde oxidase activity.
    Beedham C; Bruce SE; Critchley DJ; al-Tayib Y; Rance DJ
    Eur J Drug Metab Pharmacokinet; 1987; 12(4):307-10. PubMed ID: 3130251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.
    Beedham C; Critchley DJ; Rance DJ
    Arch Biochem Biophys; 1995 Jun; 319(2):481-90. PubMed ID: 7786031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase.
    Acheampong AA; Chien DS; Lam S; Vekich S; Breau A; Usansky J; Harcourt D; Munk SA; Nguyen H; Garst M; Tang-Liu D
    Xenobiotica; 1996 Oct; 26(10):1035-55. PubMed ID: 8905918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Carbazeran 4-Oxidation and
    Xie J; Saburulla NF; Chen S; Wong SY; Yap ZP; Zhang LH; Lau AJ
    Drug Metab Dispos; 2019 Jan; 47(1):26-37. PubMed ID: 30337443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
    Sugihara K; Kitamura S; Tatsumi K
    Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde oxidase activity in fresh human skin.
    Manevski N; Balavenkatraman KK; Bertschi B; Swart P; Walles M; Camenisch G; Schiller H; Kretz O; Ling B; Wettstein R; Schaefer DJ; Pognan F; Wolf A; Litherland K
    Drug Metab Dispos; 2014 Dec; 42(12):2049-57. PubMed ID: 25249692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
    Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
    Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.
    Austin NE; Baldwin SJ; Cutler L; Deeks N; Kelly PJ; Nash M; Shardlow CE; Stemp G; Thewlis K; Ayrton A; Jeffrey P
    Xenobiotica; 2001; 31(8-9):677-86. PubMed ID: 11569533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications.
    Diamond S; Boer J; Maduskuie TP; Falahatpisheh N; Li Y; Yeleswaram S
    Drug Metab Dispos; 2010 Aug; 38(8):1277-85. PubMed ID: 20421447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations.
    Tatsumi K; Kitamura S; Narai N
    Cancer Res; 1986 Mar; 46(3):1089-93. PubMed ID: 3943085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline metabolism by the rat liver microsomal system.
    Lohmann SM; Miech RP
    J Pharmacol Exp Ther; 1976 Jan; 196(1):213-25. PubMed ID: 1246012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial characterization of hepatic aldehyde dehydrogenase from the baboon.
    Alderman J; Sanny CG; Gordon ER; Lieber CS
    Prog Clin Biol Res; 1982; 114():77-89. PubMed ID: 7163338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain differences of liver aldehyde oxidase activity in rats.
    Sugihara K; Kitamura S; Tatsumi K
    Biochem Mol Biol Int; 1995 Nov; 37(5):861-9. PubMed ID: 8624491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.
    Itoh K; Yamamura M; Takasaki W; Sasaki T; Masubuchi A; Tanaka Y
    Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.